scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-065X.2011.01056.X |
P698 | PubMed publication ID | 22017433 |
P50 | author | Jennifer L Gommerman | Q56987206 |
P2093 | author name string | Leslie Summers deLuca | |
P2860 | cites work | Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon | Q24294921 |
TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor | Q24300996 | ||
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity | Q24301401 | ||
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 | ||
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
A lymphotoxin-beta-specific receptor | Q24312186 | ||
A fourth IkappaB protein within the NF-kappaB signaling module | Q24676472 | ||
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system | Q43977064 | ||
Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease | Q44118287 | ||
Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. | Q44130049 | ||
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 | ||
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming | Q45397464 | ||
CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion | Q45418190 | ||
Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system | Q45739093 | ||
Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway | Q45745997 | ||
Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. | Q46496003 | ||
Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling | Q46518707 | ||
IL-21R on T cells is critical for sustained functionality and control of chronic viral infection | Q46697142 | ||
Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production | Q46892881 | ||
Cooperation between helper T cells and cytotoxic T lymphocyte precursors | Q46908739 | ||
Sustained IL-12 signaling is required for Th1 development | Q47305582 | ||
Lymph node genesis is induced by signaling through the lymphotoxin beta receptor | Q47713223 | ||
The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues | Q47713235 | ||
Systemic administration of antigen-loaded CD40-deficient dendritic cells mimics soluble antigen administration | Q47867764 | ||
Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis | Q47927327 | ||
The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes | Q47929660 | ||
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions | Q47982736 | ||
Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 | ||
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 | ||
Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis | Q47997496 | ||
Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis | Q48709458 | ||
Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. | Q51700316 | ||
CD40 on APCs is needed for optimal programming, maintenance, and recall of CD8+ T cell memory even in the absence of CD4+ T cell help. | Q51966220 | ||
Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. | Q51980899 | ||
Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity. | Q52013235 | ||
Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. | Q52047087 | ||
Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. | Q54664601 | ||
Lymphocyte Cytotoxicity in vitro: Activation and Release of a Cytotoxic Factor | Q59095839 | ||
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues | Q24685416 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues | Q28141400 | ||
Molecular and biological characterization of a murine ligand for CD40 | Q28186605 | ||
A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells | Q28187669 | ||
Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis | Q28207830 | ||
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway | Q28214369 | ||
Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling | Q28511980 | ||
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation | Q28584897 | ||
Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice | Q28587819 | ||
In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens | Q29615098 | ||
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages | Q29618421 | ||
Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice | Q29618716 | ||
TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling | Q33707599 | ||
Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function | Q33776116 | ||
Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis | Q33800151 | ||
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs | Q33864629 | ||
Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor | Q33883378 | ||
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo | Q33931653 | ||
Inflammatory cytokines as a third signal for T cell activation | Q33936084 | ||
Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory | Q33946269 | ||
Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways | Q34173731 | ||
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory | Q34190038 | ||
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | Q34258651 | ||
Role of lymphotoxin alpha in T-cell responses during an acute viral infection. | Q34336955 | ||
Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice | Q34359535 | ||
Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand | Q34367466 | ||
LTβR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells | Q34549822 | ||
Effector and memory CTL differentiation | Q34584974 | ||
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease | Q34788330 | ||
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease | Q35219029 | ||
A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. | Q35679191 | ||
CD40/CD154 interactions at the interface of tolerance and immunity | Q35698455 | ||
Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells | Q39834545 | ||
A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling | Q40078976 | ||
CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine | Q40618314 | ||
Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells | Q40622324 | ||
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes | Q40669542 | ||
The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways | Q40696432 | ||
Interleukin-12 and its role in the generation of TH1 cells | Q40712406 | ||
CD40-mediated activation of NF-kappa B in airway epithelial cells | Q40717817 | ||
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity | Q40785578 | ||
High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization | Q40937646 | ||
Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. | Q41275876 | ||
Functions of CD40 on B cells, dendritic cells and other cells | Q41514641 | ||
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells | Q41564337 | ||
Lymphotoxin-beta-deficient mice show defective antiviral immunity. | Q41679119 | ||
Expression of lymphotoxin-alphabeta on antigen-specific T cells is required for DC function | Q41905092 | ||
CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization | Q42060069 | ||
A vital role for interleukin-21 in the control of a chronic viral infection | Q42541944 | ||
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help | Q42642562 | ||
CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal | Q42834238 | ||
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling | Q43142702 | ||
A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection | Q43511891 | ||
Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis | Q43710164 | ||
A fail-safe mechanism for maintaining self-tolerance | Q36231679 | ||
Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon | Q36269434 | ||
Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations | Q36352807 | ||
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells | Q36367286 | ||
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
CD4+ but not CD8+ cells are essential for allorejection | Q36367566 | ||
The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli | Q36368355 | ||
Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor | Q36369174 | ||
Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. | Q36370873 | ||
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function | Q36370978 | ||
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance | Q36376611 | ||
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help | Q36380318 | ||
TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor | Q36380989 | ||
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN | Q36402326 | ||
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection | Q36402851 | ||
Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes | Q36403897 | ||
Prospect of targeting the CD40 pathway for cancer therapy | Q36743436 | ||
TRAF3 and its biological function | Q36882586 | ||
TRAF proteins in CD40 signaling | Q36882612 | ||
Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways | Q37036159 | ||
Programming for CD8 T cell memory development requires IL-12 or type I IFN | Q37110371 | ||
Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice | Q37207114 | ||
The role of positive costimulatory molecules in transplantation and tolerance | Q37236949 | ||
Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus | Q37243919 | ||
The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells | Q37262669 | ||
ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction | Q37326558 | ||
Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response | Q37397090 | ||
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation | Q37474948 | ||
The role of CD40 and CD154/CD40L in dendritic cells | Q37518524 | ||
Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis | Q38288045 | ||
IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines | Q38289507 | ||
Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation | Q38294592 | ||
IL-21 is required to control chronic viral infection | Q39328817 | ||
P433 | issue | 1 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 85-98 | |
P577 | publication date | 2011-11-01 | |
P1433 | published in | Immunological Reviews | Q15724582 |
P1476 | title | LTβR and CD40: working together in dendritic cells to optimize immune responses | |
P478 | volume | 244 |
Q21133637 | Acetylcorynoline impairs the maturation of mouse bone marrow-derived dendritic cells via suppression of IκB kinase and mitogen-activated protein kinase activities |
Q34488528 | CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV. |
Q38260032 | Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model |
Q39193752 | Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses |
Q54353561 | Dryocrassin suppresses immunostimulatory function of dendritic cells and prolongs skin allograft survival. |
Q37138965 | Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells |
Q38874554 | Involvement of the cytoplasmic cysteine-238 of CD40 in its up-regulation of CD23 expression and its enhancement of TLR4-triggered responses |
Q83409279 | Lymphotoxin and the amazing technicolor circus of intestinal homeostasis |
Q38113962 | Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules |
Q37576573 | Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues |
Q89168207 | Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessment |
Q38746598 | T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells |
Q38129083 | The contextual role of TNFR family members in CD8(+) T-cell control of viral infections |
Search more.